000 | 00907 a2200265 4500 | ||
---|---|---|---|
005 | 20250518030339.0 | ||
264 | 0 | _c20200110 | |
008 | 202001s 0 0 eng d | ||
022 | _a1873-233X | ||
024 | 7 |
_a10.1097/AOG.0000000000003194 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSoper, David E | |
245 | 0 | 0 |
_aPreventing Surgical Site Infection: Approaching Zero Tolerance. _h[electronic resource] |
260 |
_bObstetrics and gynecology _c04 2019 |
||
300 |
_a624-625 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aSurgical Wound Infection |
650 | 0 | 4 | _aUterine Myomectomy |
773 | 0 |
_tObstetrics and gynecology _gvol. 133 _gno. 4 _gp. 624-625 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/AOG.0000000000003194 _zAvailable from publisher's website |
999 |
_c29476254 _d29476254 |